Publications for Minghao Zhong minghaozhong@gmail.com

Argani, P., Zhong, M., Reuter, V. E., Fallon, J. T., Epstein, J. I., Netto, G. J., & Antonescu, C. R. (2016). TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. The American Journal of Surgical Pathology, 40(6), 723-737. doi:10.1097/PAS.0000000000000631

Babayeva, S., Fanucchi, M., Puccio, C., Lafaro, R., Shakil, F., Fallon, J. T., . . . Zhong, M. (2016). Programmed death ligand-1 (PD-L1) expression in operable non-small cell lung cancer (NSCLC) by immunohistochemical analysis. Laboratory Investigation, 96(Suppl 1), 467A.

Babayeva, S., Fanucchi, M., Puccio, C., Lafaro, R., Shakil, F., Fallon, J. T., . . . Zhong, M. (2016). Programmed death ligand-1 (PD-L1) expression in operable non-small cell lung cancer (NSCLC) by immunohistochemical analysis. Modern Pathology, 29(Suppl 2), 467A.

Babayeva, S., Huang, W., Islam, H., Fallon, J. T., & Zhong, M. (2016). Detection gene fusion(s) in melanotic Xp11 translocation renal cancer by RNA-seq. Laboratory Investigation, 96(Suppl 1), 215A.

Babayeva, S., Huang, W., Islam, H., Fallon, J. T., & Zhong, M. (2016). Detection gene fusion(s) in melanotic Xp11 translocation renal cancer by RNA-seq. Modern Pathology, 29(Suppl 2), 215A.

Babayeva, S., Zhang, H., Fanucchi, M., Lafaro, R., Yusuf, Y., Fallon, J. T., & Zhong, M. (2016). Programmed death ligand-1 (PD-L1) expression in squamous cell carcinoma from different anatomic sites. Laboratory Investigation, 96(Suppl 1), 467A.

Babayeva, S., Zhang, H., Fanucchi, M., Lafaro, R., Yusuf, Y., Fallon, J. T., & Zhong, M. (2016). Programmed death ligand-1 (PD-L1) expression in squamous cell carcinoma from different anatomic sites. Modern Pathology, 29(Suppl 2), 467A.

Khani, F., Diolombi, M. L., Khattar, P., Huang, W., Fallon, J. T., Epstein, J. I., & Zhong, M. (2016). Benign and malignant Brenner tumors show an absence of TERT promoter mutations that are commonly present in urothelial carcinoma. The American Journal of Surgical Pathology, 40(9), 1291-1295. doi:10.1097/PAS.0000000000000680

Khani, F., Diolombi, M. L., Khattar, P., Huang, W., Fallon, J. T., Epstein, J. I., & Zhong, M. (2016). Malignant Brenner tumors show an absence of TERT promoter mutations which are commonly present in urothelial carcinoma. Modern Pathology, 29(Suppl 2), 291A. doi:10.1097/PAS.0000000000000680

Khattar, P., Huang, W., Yang, X., Adem, P. V., Fallon, J. T., & Zhong, M. (2016). RNA-seq study of TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa). Laboratory Investigation, 96(Suppl 1), 20A-21A.

Khattar, P., Huang, W., Yang, X., Adem, P. V., Fallon, J. T., & Zhong, M. (2016). RNA-seq study of TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa). Modern Pathology, 29(Suppl 2), 20A-21A.

Khattar, P., Khani, F., Diolombi, M. L., Huang, W., Fallon, J. T., Epstein, J. I., & Zhong, M. (2016). Whole exon sequencing of malignant brenner tumor: Differences from conventional urothelial carcinoma. Laboratory Investigation, 96(Suppl 1), 292A.

Khattar, P., Khani, F., Diolombi, M. L., Huang, W., Fallon, J. T., Epstein, J. I., & Zhong, M. (2016). Whole exon sequencing of malignant brenner tumor: Differences from conventional urothelial carcinoma. Modern Pathology, 29(Suppl 2), 292A.

Kurtis, B., Zhuge, J., Ojaimi, C., Ye, F., Cai, D., Fallon, J. T.,. . . Zhong, M. (2016). Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Annals of Diagnostic Pathology, 21, 7-11. doi:10.1016/j.anndiagpath.2015.12.002

Saeed, F., & Zhong, M. (2016). Sclerosing pneumocytoma, a mimicker of lung adenocarcinoma: Case report. American Journal of Clinical Pathology, 146(Suppl 1), 251. doi:10.1093/ajcp/aqw159.022

Volyanskyy, K., Cheung, Y., Zhong, M., Fallon, J. T., Carmack, C. E., & Dimitrova, N. (2016). Molecular subtyping using un-supervised machine learning methods with application to renal cell carcinoma TCGA data sets. Journal of Molecular Diagnostics, 18(6), 994.

Yoon, E., Hajiyeva, S., Barasch, S., Volyanskyy, K., Dimitrova, N., Fallon, J. T., . . . Zhong, M. (2016). Loss of fructose-1,6-bisphosphatase 1 expression in kidney neoplasm. American Journal of Clinical Pathology, 146(Suppl 1), S141. doi:10.1093/ajcp/aqw159.090

Yoon, E., Hennrick, K., Mao, Y., Volyanskyy, K., Dimitrova, N., Fallon, J. T., & Zhong, M. (2016). Down-regulation of fructose-1,6-bisphosphatase (FBP1) in triple-negative breast cancer. Laboratory Investigation, 96(Suppl 1), 79A. This material can be found here.

Yoon, E., Hennrick, K., Mao, Y., Volyanskyy, K., Dimitrova, N., Fallon, J. T., & Zhong, M. (2016). Down-regulation of fructose-1,6-bisphosphatase (FBP1) in triple-negative breast cancer. Modern Pathology, 29(Suppl 2), 79A. This material can be found here.

Zhong, M., Mankovich, A., Zhuge, J., Huang, W., Wang, G., Dimitrova, N., . . . Fallon, J. T. (2016). Validation of an amplicon-based NGS cancer panel and informatics pipeline as potential replacement for sanger and PCR-based methods for somatic mutation detection in a hospital clinical laboratory. Journal of Molecular Diagnostics, 18(6), 1005.

Zhong, M., Vail, E., Huang, W., Mayogowda, P., Dimitrova, N., Fallon, J. T., & Zhong, M. (2016). Genomic mutational analysis of colorectal adenocarcinoma in patients under the age of 40. Journal of Molecular Diagnostics, 18(6), 1028.

Cheng, K. A., Kurtis, B., Babayeva, S., Zhuge, J.,  Lafaro, R. J., Fallon, J. T.,. . . Zhong, M. (2015). Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites. Annals of Diagnostic Pathology, 19(3), 146-148. doi:10.1016/j.anndiagpath.2015.03.005

Huang, W., Goldfischer, M., Babayeva, S., Mao, Y., Dimitrova, N., Fallon, J. T., . . . Zhong, M. (2015). Identification of a novel PARP14-TFE3 gene fusion from 10-year-old FFPE tissue by RNA-seq. Genes, Chromosomes & Cancer, 54(8), 500-505. doi:10.1002/gcc.22261

Vail, E., Zheng, X., Zhou, M., Yang, X., Fallon, J. T., Epstein, J. I., & Zhong, M. (2015). Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder. Annals of Diagnostic Pathology, 19(5), 301-305. doi:10.1016/j.anndiagpath.2015.06.007

Zheng, X., Liu, D., Fallon, J. T., & Zhong, M.. (2015). Distinct genetic alterations in small cell carcinoma from different anatomic sites. Experimental Hematology & Oncology, 4, [Article 2].  doi:10.1186/2162-3619-4-2